| Name: | Dabigatran Impurity P |
| Catalogue No. | VL1760001 |
| CAS No. | 1408238-37-8 |
| Molecular Formula | C₃₂H₃₆N₆O₆ |
| Molecular Weight | 600.66 |
| Status | In-stock |
| IUPAC Name | 3-(2-(((4-(((Hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic Acid |
| Description | Dabigatran Impurity P (CAS No.: 1408238-37-8) or 3-(2-(((4-(((Hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic Acid is an impurity of Dabigatran which is an oral direct thrombin inhibitor and is evaluated for the prevention of stroke in patients having atrial fibrillation. |
| References | Pantović, Jasmina, et al. “Development of Liquid Chromatographic Method for the Analysis of Dabigatran Etexilate Mesilate and Its Ten Impurities Supported by Quality-By-Design Methodology.” Journal of Pharmaceutical and Biomedical Analysis, vol. 111, July 2015, pp. 7–13,https://doi.org/10.1016/j.jpba.2015.03.009.Legrand, Matthieu. “The Use of Dabigatran in Elderly Patients.” Archives of Internal Medicine, vol. 171, no. 14, July 2011, p. 1285,https://doi.org/10.1001/archinternmed.2011.314. |
